Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-05-20 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTAUBAN (82000), Tarn-et-Garonne
PHARMACIE VERTE DE L'HIPPODROME : revenue, balance sheet and financial ratios
PHARMACIE VERTE DE L'HIPPODROME is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTAUBAN (82000),
this company of category PME
shows in 2022 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE VERTE DE L'HIPPODROME (SIREN 811485341)
Indicator
2025
2022
2021
Revenue
N/C
1 593 513 €
1 354 697 €
Net income
109 763 €
78 636 €
62 540 €
EBITDA
N/C
118 399 €
97 274 €
Net margin
N/C
4.9%
4.6%
Revenue and income statement
In 2025, PHARMACIE VERTE DE L'HIPPODROME generates positive net income of 110 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 63 k€ -> 110 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
109 763 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 67%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
67.463%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.793%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE VERTE DE L'HIPPODROME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2025
Debt ratio
210.15
141.351
67.463
Financial autonomy
27.332
35.71
50.793
Repayment capacity
6.379
4.386
None
Cash flow / Revenue
5.273%
5.737%
None%
Sector positioning
Debt ratio
67.462025
2021
2022
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-19 pts over 3 years
In 2025, the debt ratio of PHARMACIE VERTE DE L'HIPP... (67.46) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.79%2025
2021
2022
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+19 pts over 3 years
In 2025, the financial autonomy of PHARMACIE VERTE DE L'HIPP... (50.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.39 years2022
2021
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average-12 pts over 2 years
In 2022, the repayment capacity of PHARMACIE VERTE DE L'HIPP... (4.39) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 378.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
378.049
Liquidity indicators evolution PHARMACIE VERTE DE L'HIPPODROME
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2025
Liquidity ratio
334.935
382.025
378.049
Interest coverage
2.533
2.236
None
Sector positioning
Liquidity ratio
378.052025
2021
2022
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of PHARMACIE VERTE DE L'HIPP... (378.05) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
2.24x2022
2021
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE VERTE DE L'HIPP... (2.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE VERTE DE L'HIPPODROME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2025
Operating WCR
92 106 €
86 831 €
0 €
Inventory turnover (days)
31
26
0
Customer payment term (days)
3
1
0
Supplier payment term (days)
27
22
0
Positioning of PHARMACIE VERTE DE L'HIPPODROME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE VERTE DE L'HIPPODROME is estimated at
1 743 598 €
(range 1 183 214€ - 2 735 945€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1183k€1743k€2735k€
1 743 598 €Range: 1 183 214€ - 2 735 945€
NAF 5 année 2025
Valuation method used
Net Income Multiple
109 763 €
×
15.9x
=1 743 598 €
Range: 1 183 214€ - 2 735 946€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE VERTE DE L'HIPPODROME with other companies in the same sector:
Frequently asked questions about PHARMACIE VERTE DE L'HIPPODROME
What is the revenue of PHARMACIE VERTE DE L'HIPPODROME ?
The revenue of PHARMACIE VERTE DE L'HIPPODROME in 2022 is 1.6 M€.
Is PHARMACIE VERTE DE L'HIPPODROME profitable?
Yes, PHARMACIE VERTE DE L'HIPPODROME generated a net profit of 110 k€ in 2025.
Where is the headquarters of PHARMACIE VERTE DE L'HIPPODROME ?
The headquarters of PHARMACIE VERTE DE L'HIPPODROME is located in MONTAUBAN (82000), in the department Tarn-et-Garonne.
Where to find the tax return of PHARMACIE VERTE DE L'HIPPODROME ?
The tax return of PHARMACIE VERTE DE L'HIPPODROME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE VERTE DE L'HIPPODROME operate?
PHARMACIE VERTE DE L'HIPPODROME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart